Pregnancy outcomes in women screened for tuberculosis infection in Swedish antenatal care.

Latent tuberculosis infection TBI preeclampsia pregnancy screening stillbirth tuberculosis

Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
12 Aug 2023
Historique:
received: 24 02 2023
revised: 23 05 2023
accepted: 08 08 2023
medline: 13 8 2023
pubmed: 13 8 2023
entrez: 12 8 2023
Statut: aheadofprint

Résumé

Tuberculosis (TB) disease has been associated with pregnancy complications. However, the potential impact of TB infection (TBI) on pregnancy outcome is unknown. To investigate this, we conducted a register-based study in immigrant women screened with QuantiFERON assays for TBI in antenatal care in Sweden. Women with history of immigration from TB-endemic countries were eligible for inclusion if national identification numbers and available QuantiFERON results obtained during pregnancy 2014-2018 were available. QuantiFERON results were linked to data on maternal characteristics and pregnancy outcomes from the national Pregnancy and Patient Registers. TBI was defined as nil-corrected QuantiFERON result ≥0.35 IU/ml, in the absence of TB disease. Pregnancies in women with TB disease or HIV infection were excluded, as well as multiplex pregnancies, pregnancies resulting in miscarriage, and pregnancies occurring >10 years after immigration. Odds of defined adverse pregnancy outcomes were compared by maternal TBI status using mixed effects logistic regression with adjustment for maternal age and region of origin. In total, 7,408 women with 12,443 pregnancies were included. In multivariable analysis, stillbirth (adjusted Odds ratio [AOR] 1.90, 95% confidence interval [CI] 1.13-3.21, p=0.016), severe preeclampsia (AOR 1.62, 95% CI 1.03-2.56, p=0.036), low birthweight (<2500 grams; AOR 1.38, 95% CI 1.01-1.88, p=0.041) and emergency Caesarean section (AOR 1.28, 95% CI 1.02-1.63, p=0.033) were significantly associated with TBI. Among immigrant women seeking antenatal care in Sweden, TBI was independently associated with adverse pregnancy outcomes. Further studies are needed to corroborate these findings and to explore mechanisms involved.

Sections du résumé

BACKGROUND BACKGROUND
Tuberculosis (TB) disease has been associated with pregnancy complications. However, the potential impact of TB infection (TBI) on pregnancy outcome is unknown. To investigate this, we conducted a register-based study in immigrant women screened with QuantiFERON assays for TBI in antenatal care in Sweden.
METHODS METHODS
Women with history of immigration from TB-endemic countries were eligible for inclusion if national identification numbers and available QuantiFERON results obtained during pregnancy 2014-2018 were available. QuantiFERON results were linked to data on maternal characteristics and pregnancy outcomes from the national Pregnancy and Patient Registers. TBI was defined as nil-corrected QuantiFERON result ≥0.35 IU/ml, in the absence of TB disease. Pregnancies in women with TB disease or HIV infection were excluded, as well as multiplex pregnancies, pregnancies resulting in miscarriage, and pregnancies occurring >10 years after immigration. Odds of defined adverse pregnancy outcomes were compared by maternal TBI status using mixed effects logistic regression with adjustment for maternal age and region of origin.
RESULTS RESULTS
In total, 7,408 women with 12,443 pregnancies were included. In multivariable analysis, stillbirth (adjusted Odds ratio [AOR] 1.90, 95% confidence interval [CI] 1.13-3.21, p=0.016), severe preeclampsia (AOR 1.62, 95% CI 1.03-2.56, p=0.036), low birthweight (<2500 grams; AOR 1.38, 95% CI 1.01-1.88, p=0.041) and emergency Caesarean section (AOR 1.28, 95% CI 1.02-1.63, p=0.033) were significantly associated with TBI.
CONCLUSION CONCLUSIONS
Among immigrant women seeking antenatal care in Sweden, TBI was independently associated with adverse pregnancy outcomes. Further studies are needed to corroborate these findings and to explore mechanisms involved.

Identifiants

pubmed: 37572363
pii: 7241777
doi: 10.1093/cid/ciad465
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America.

Auteurs

John Walles (J)

Clinical Infection Medicine, Department of Translational Medicine, Lund University, Malmö, Sweden.
Department of Infectious Diseases, Central Hospital, Kristianstad, Sweden.
Department of Clinical Microbiology, Infection Control and Prevention, Skåne University Hospital Lund, Sweden.

Niclas Winqvist (N)

Skåne Regional Office for Infectious Disease Control and Prevention, Malmö, Sweden.

Stefan R Hansson (SR)

Division of Obstetrics and Gynaecology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
Skåne University Hospital, Lund, Sweden.

Erik Sturegård (E)

Clinical Infection Medicine, Department of Translational Medicine, Lund University, Malmö, Sweden.
Department of Clinical Microbiology, Infection Control and Prevention, Skåne University Hospital Lund, Sweden.

Haitham Baqir (H)

Department of Clinical Microbiology, Linköping University Hospital, Linköping, Sweden.

Anna Westman (A)

Department of Infectious Diseases, Danderyd Hospital, Stockholm, Sweden.
Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska University Hospital Laboratory, Stockholm, Sweden.

Torbjörn Kjerstadius (T)

Laboratory Medicine, Clinical Microbiology, Central Hospital, Karlstad, Sweden.

Thomas Schön (T)

Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
Department of Infectious Diseases, Kalmar County Hospital, Linköping University, Kalmar, Sweden.
Department of Infectious Diseases, Linköping University, Linköping, Sweden.

Per Björkman (P)

Clinical Infection Medicine, Department of Translational Medicine, Lund University, Malmö, Sweden.
Department of Infectious Diseases, Skåne University Hospital, Malmö, Sweden.

Classifications MeSH